137 related articles for article (PubMed ID: 3408646)
1. Thymidine kinase activities in mononuclear leukocytes and serum from breast cancer patients.
McKenna PG; O'Neill KL; Abram WP; Hannigan BM
Br J Cancer; 1988 Jun; 57(6):619-22. PubMed ID: 3408646
[TBL] [Abstract][Full Text] [Related]
2. Can thymidine kinase levels in breast tumors predict disease recurrence?
O'Neill KL; Hoper M; Odling-Smee GW
J Natl Cancer Inst; 1992 Dec; 84(23):1825-8. PubMed ID: 1433372
[TBL] [Abstract][Full Text] [Related]
3. A clinical evaluation of the TK 210 ELISA in sera from breast cancer patients demonstrates high sensitivity and specificity in all stages of disease.
Kumar JK; Aronsson AC; Pilko G; Zupan M; Kumer K; Fabjan T; Osredkar J; Eriksson S
Tumour Biol; 2016 Sep; 37(9):11937-11945. PubMed ID: 27079872
[TBL] [Abstract][Full Text] [Related]
4. The clinical significance of thymidine kinase 1 measurement in serum of breast cancer patients using anti-TK1 antibody.
He Q; Zou L; Zhang PA; Lui JX; Skog S; Fornander T
Int J Biol Markers; 2000; 15(2):139-46. PubMed ID: 10883887
[TBL] [Abstract][Full Text] [Related]
5. Serum thymidine kinase 1 activity as a pharmacodynamic marker of cyclin-dependent kinase 4/6 inhibition in patients with early-stage breast cancer receiving neoadjuvant palbociclib.
Bagegni N; Thomas S; Liu N; Luo J; Hoog J; Northfelt DW; Goetz MP; Forero A; Bergqvist M; Karen J; Neumüller M; Suh EM; Guo Z; Vij K; Sanati S; Ellis M; Ma CX
Breast Cancer Res; 2017 Nov; 19(1):123. PubMed ID: 29162134
[TBL] [Abstract][Full Text] [Related]
6. Selective inhibition of thymidine kinase isoenzymes by (E)-5-(2-bromovinyl)-2-deoxyuridine.
Armstrong B; Modjtahedi H; O'Neill KL; Hannigan BM; McKenna PG
Biochem Soc Trans; 1990 Apr; 18(2):270. PubMed ID: 2379709
[No Abstract] [Full Text] [Related]
7. Breast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: implications of using serum TK1 as a biomarker.
Jagarlamudi KK; Hansson LO; Eriksson S
BMC Cancer; 2015 Feb; 15():66. PubMed ID: 25881026
[TBL] [Abstract][Full Text] [Related]
8. Elevated serum and mononuclear leukocyte thymidine kinase activities in patients with cancer.
O'Neill K; Abram P; Hannigan B; McKenna G
Ir Med J; 1987 Sep; 80(9):264-5. PubMed ID: 3667196
[No Abstract] [Full Text] [Related]
9. Breast tumour thymidine kinase levels and disease recurrence.
O'Neill KL; McKelvey VJ; Hoper M; Monteverde H; Odling-Smee GW; Logan H; Abram WP; McKenna PG
Med Lab Sci; 1992 Dec; 49(4):244-7. PubMed ID: 1339926
[TBL] [Abstract][Full Text] [Related]
10. Thymidine kinase in breast cancer.
Robertson JF; O'Neill KL; Thomas MW; McKenna PG; Blamey RW
Br J Cancer; 1990 Oct; 62(4):663-7. PubMed ID: 2223587
[TBL] [Abstract][Full Text] [Related]
11. Serum thymidine kinase 1 activity in breast cancer.
Nisman B; Allweis T; Kaduri L; Maly B; Gronowitz S; Hamburger T; Peretz T
Cancer Biomark; 2010; 7(2):65-72. PubMed ID: 21178264
[TBL] [Abstract][Full Text] [Related]
12. Comparison of diagnostic and prognostic performance of two assays measuring thymidine kinase 1 activity in serum of breast cancer patients.
Nisman B; Allweis T; Kadouri L; Mali B; Hamburger T; Baras M; Gronowitz S; Peretz T
Clin Chem Lab Med; 2013 Feb; 51(2):439-47. PubMed ID: 23093267
[TBL] [Abstract][Full Text] [Related]
13. Elevated levels of thymidine kinase 1 peptide in serum from patients with breast cancer.
Carlsson L; Larsson A; Lindman H
Ups J Med Sci; 2009; 114(2):116-20. PubMed ID: 19396699
[TBL] [Abstract][Full Text] [Related]
14. Prognostic relevance of thymidine kinase isozymes in adult non-Hodgkin's lymphoma.
Ellims PH; Eng Gan T; Medley G; Van Der Weyden MB
Blood; 1981 Nov; 58(5):926-30. PubMed ID: 7296003
[TBL] [Abstract][Full Text] [Related]
15. Thymidine kinase isoenzymes in chronic lymphocytic leukaemia.
Ellims PH; Gan TE; Van der Weyden MB
Br J Haematol; 1981 Nov; 49(3):479-81. PubMed ID: 7295590
[TBL] [Abstract][Full Text] [Related]
16. Thymidine kinase 1 in serum predicts increased risk of distant or loco-regional recurrence following surgery in patients with early breast cancer.
He Q; Fornander T; Johansson H; Johansson U; Hu GZ; Rutqvist LE; Skog S
Anticancer Res; 2006; 26(6C):4753-9. PubMed ID: 17214336
[TBL] [Abstract][Full Text] [Related]
17. Serum thymidine kinase 1 activity in solid tumor (breast and colorectal cancer) patients treated with adjuvant chemotherapy.
Bolayirli M; Papila C; Korkmaz GG; Papila B; Aydoğan F; Karataş A; Uzun H
J Clin Lab Anal; 2013 May; 27(3):220-6. PubMed ID: 23686779
[TBL] [Abstract][Full Text] [Related]
18. Thymidine kinase and alpha-fetoprotein as biochemical markers of hepatocarcinogenesis induced by 3'-methyl-4-dimethylaminoazobenzene treatment in rats.
Sakamoto S; Hirai H; Taga H; Uchikoshi T; Sunaga T; Endo Y; Kuwa K; Kudo H; Kawachi Y; Kasahara N
Carcinogenesis; 1990 Jan; 11(1):145-50. PubMed ID: 1688518
[TBL] [Abstract][Full Text] [Related]
19. Thymidine kinase in human leukemia--expression of three isoenzyme variants in six patients with chronic myelocytic leukemia.
Munch-Petersen B
Leuk Res; 1990; 14(1):39-45. PubMed ID: 2304355
[TBL] [Abstract][Full Text] [Related]
20. Lymphocyte thymidine kinase and treatment response in acute lymphocytic leukemia.
Russo SA; Harris MB; Greengard O
Leuk Res; 1987; 11(2):149-54. PubMed ID: 3469483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
